MARKET

OABI

OABI

OmniAb, Inc.
NASDAQ
1.850
-0.010
-0.54%
After Hours: 1.850 0 0.00% 16:10 12/31 EST
OPEN
1.880
PREV CLOSE
1.860
HIGH
1.890
LOW
1.800
VOLUME
439.14K
TURNOVER
--
52 WEEK HIGH
4.020
52 WEEK LOW
1.220
MARKET CAP
266.32M
P/E (TTM)
-3.1329
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OABI last week (1222-1226)?
Weekly Report · 12/29/2025 09:06
Weekly Report: what happened at OABI last week (1215-1219)?
Weekly Report · 12/22/2025 09:06
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Viridian Therapeutics (VRDN) and OmniAb (OABI)
TipRanks · 12/16/2025 12:30
Innovative OmniUltra Platform Drives Buy Rating for OmniAb with Strategic Growth Potential
TipRanks · 12/16/2025 11:35
OmniAb Inc. Unveils OmniUltra Platform for Discovery of Novel Mini-Proteins and Structured Peptides
Reuters · 12/15/2025 21:26
OmniAb Unveils OmniUltra Platform to Expand Antibody Discovery Capabilities
Reuters · 12/15/2025 21:05
Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
Barchart · 12/15/2025 15:05
OmniAb management to meet virtually with Craig-Hallum
TipRanks · 12/15/2025 14:55
More
About OABI
OmniAb, Inc. licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners’ drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.

Webull offers OmniAB Inc stock information, including NASDAQ: OABI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OABI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OABI stock methods without spending real money on the virtual paper trading platform.